Circulating Methylated-HOXA9 Tumor DNA as a Biomarker in Recurrent Breast Cancer
In this MEDtalk, MD Stine Bakkesen Bruun presents interesting findings on a potential new biomarker for prognosis and mortality in recurrent breast cancer. The biomarker is circulating methylated-HOXA9 tumor DNA, as this gene may act as a tumor suppressor in carcinomas and induce breast cancer progression.
Få tilgang
Hvis du er lege, sykepleier eller annen helsepersonell, kan du få tilgang til hele artikkelen ved å opprette en profil på BestPractice Nordic.
- Få tilgang
- Hvis du allerede har en profil: Logg in
